Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-11-13 4:00 pm Purchase | 2026-09-30 | 13G | LEONABIO INC LONA | Spruce Street Capital LP | 393,700 4.200% | 393,700 (New Position) | Filing History |
| 2026-11-04 4:00 pm Purchase | 2026-10-28 | 13G | LEONABIO INC LONA | Great Point Partners, LLC | 474,345 5.030% | 474,345 (New Position) | Filing History |
| 2026-10-28 3:37 pm Sale | 2026-10-26 | 13D | LEONABIO INC LONA | Sermonix Pharmaceuticals, Inc. | 3,149,470 25.100% | -2,352,932 (-42.76%) | Filing History |
| 2026-10-26 4:00 pm Unchanged | 2026-10-26 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,889,403 19.990% | 0 (Unchanged) | Filing History |
| 2026-08-31 4:31 pm Purchase | 2026-08-24 | 13D | LEONABIO INC LONA | Sermonix Pharmaceuticals, Inc. | 5,502,402 36.900% | 5,502,402 (New Position) | Filing History |
| 2026-08-25 4:00 pm Purchase | 2026-08-22 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,889,403 19.990% | 7,033 (+0.37%) | Filing History |
| 2026-08-20 10:34 am Purchase | 2026-08-18 | 13G | LEONABIO INC LONA | ACORN BIOVENTURES, L.P. | 1,492,521 12.100% | 896,453 (+150.39%) | Filing History |
| 2026-05-15 8:03 pm Purchase | 2026-03-31 | 13G | LEONABIO INC LONA | ADAR1 Capital Management LLC | 727,481 7.700% | 727,481 (New Position) | Filing History |
| 2026-05-07 4:19 pm Purchase | 2026-05-05 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,882,370 19.990% | 23,048 (+1.24%) | Filing History |
| 2026-02-06 4:29 pm Sale | 2025-12-31 | 13G | LEONABIO INC LONA | Baselake Partners, LP | 75,789 1.900% | -121,692 (-61.62%) | Filing History |
| 2026-01-16 4:46 pm Sale | 2026-01-16 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,859,322 19.990% | -9,728 (-0.52%) | Filing History |
| 2026-01-08 5:29 pm Purchase | 2026-01-06 | 13G | ATHIRA PHARMA INC ATHA | ACORN BIOVENTURES, L.P. | 596,068 6.200% | 94,329 (+18.80%) | Filing History |
| 2025-12-23 5:16 pm Purchase | 2025-12-23 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 1,869,050 20.100% | 1,319,026 (+239.81%) | Filing History |
| 2025-12-23 4:46 pm Purchase | 2025-12-22 | 13G | ATHIRA PHARMA INC ATHA | ACORN BIOVENTURES, L.P. | 501,739 5.200% | 501,739 (New Position) | Filing History |
| 2025-12-22 4:30 pm Purchase | 2025-12-18 | 13D | LEONABIO INC LONA | Perceptive Advisors LLC | 550,024 13.900% | 2,089 (+0.38%) | Filing History |
| 2025-12-18 3:47 pm Sale | 2025-12-18 | 13G | ATHIRA PHARMA INC ATHA | BML Investment Partners, L.P. | 0 0.000% | -302,716 (Position Closed) | Filing History |
| 2025-11-14 4:06 pm Purchase | 2025-11-07 | 13G | LEONABIO INC LONA | Baselake Partners, LP | 197,481 5.000% | 197,481 (New Position) | Filing History |
| 2025-10-10 4:41 pm Sale | 2025-10-01 | 13G | ATHIRA PHARMA INC ATHA | Oliveira Steven Michael | 161,218 4.088% | -38,247 (-19.17%) | Filing History |
| 2025-04-16 4:22 pm Purchase | 2025-04-14 | 13G | ATHIRA PHARMA INC ATHA | Oliveira Steven Michael | 199,465 5.109% | 199,465 (New Position) | Filing History |
| 2025-02-14 10:21 am Purchase | 2024-12-31 | 13G | ATHIRA PHARMA INC ATHA | BML Investment Partners, L.P. | 302,716 7.800% | 54,271 (+21.84%) | Filing History |